FDA allows automatic 'generic' swap for brand-name insulin [View all]
Source: Associated Press
U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore.
Doctors now have to specifically prescribe whats called a biosimilar or OK substituting it for a more expensive brand-name insulin.
Wednesdays move by the Food and Drug Administration will allow pharmacists to automatically substitute the cheaper version, just as they do with generic pills for other kinds of drugs.
Its the FDAs first approval of an interchangeable biosimilar, a near-copy of an injected biologic medicine thats manufactured inside living cells. It could save diabetics and health plans millions of dollars annually and encourage other drugmakers to create more biosimilar medicines. Health data firm IQVIA projects U.S. savings from increasing use of biosimilars from 2020 through 2024 will top $100 billion.
-snip-
By LINDA A. JOHNSON
an hour ago
Read more: https://apnews.com/article/business-science-health-8c698faa57d55ce73bc7422cfd22ca89